- Home
- CAC vs SANA Comparison
CAC vs SANA Comparison
Compare CAC & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CAC | SANA |
|---|---|---|
| Founded | 1875 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 923.2M | 793.1M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CAC | SANA |
|---|---|---|
| Price | $57.71 | $2.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $47.00 | $7.80 |
| AVG Volume (30 Days) | 76.0K | ★ 3.4M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | 6.08 | ★ 17.24 |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $41,739,000.00 | N/A |
| Revenue This Year | $19.15 | N/A |
| Revenue Next Year | $6.05 | N/A |
| P/E Ratio | $21.55 | ★ N/A |
| Revenue Growth | ★ 16.96 | N/A |
| 52 Week Low | $35.00 | $2.61 |
| 52 Week High | $60.59 | $6.55 |
Technical Indicators
Market Signals| Indicator | CAC | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 37.78 |
| Support Level | $56.91 | $2.76 |
| Resistance Level | $59.21 | $3.43 |
| Average True Range (ATR) | 1.35 | 0.22 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 69.12 | 9.33 |
Price Performance
Historical ComparisonAbout CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.